1 Death |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
1.1 Death before discharge |
1 |
9 |
Risk Ratio (M‐H, Fixed, 95% CI) |
4.17 [0.25, 68.16] |
2 Endotracheal intubation |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
2.1 Endotracheal intubation in the delivery room |
1 |
9 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.0 [0.68, 1.46] |
3 Surfactant administration |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
3.1 Surfactant given in the delivery room |
1 |
9 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.65 [0.31, 1.35] |
4 Chronic lung disease |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
4.1 Moderate to severe BPD |
1 |
7 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.89 [0.33, 2.37] |
5 Pneumothorax |
1 |
|
Risk Difference (M‐H, Fixed, 95% CI) |
Subtotals only |
5.1 At any time |
1 |
9 |
Risk Difference (M‐H, Fixed, 95% CI) |
0.0 [‐0.34, 0.34] |
6 Cranial ultrasound abnormalities |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
6.1 Intraventricular haemorrhage grade 3 to 4 |
1 |
9 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.4 [0.05, 2.98] |
6.2 IVH any grade |
1 |
9 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.28 [0.07, 1.15] |
7 Retinopathy of prematurity (ROP) stage ≥ 3 |
1 |
9 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.27 [0.04, 1.68] |
8 Patent ductus arteriosus (PDA) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
8.1 PDA ‐ pharmacological treatment |
1 |
9 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.46 [0.17, 1.25] |